Carol Ward

Title: Carol Ward - Innovator in Lung Cancer Research

Introduction

Carol Ward is a prominent inventor based in Helfrantzkirch, France. She has made significant contributions to the field of cancer research, particularly in the area of lung cancer treatment. Her innovative work focuses on improving the effectiveness of chemotherapy for patients suffering from this disease.

Latest Patents

Carol Ward holds a patent for her invention titled "Determination of responders to chemotherapy." This patent describes a method for determining whether a biological sample containing human lung cancer cells is sensitive to a combination of an epidermal growth factor receptor inhibitor and a chemotherapeutic agent. The method involves assessing the overexpression of phosphorylated AKT protein and/or phosphorylated MAPK protein in the biological sample. This invention also includes methods for deriving candidate agents or selecting compositions aimed at inhibiting the progression of lung cancer in patients.

Career Highlights

Throughout her career, Carol has demonstrated a strong commitment to advancing cancer research. She is currently associated with Hoffmann-La Roche Inc., where she continues to work on innovative solutions for cancer treatment. Her dedication to improving patient outcomes is evident in her research and patent contributions.

Collaborations

Carol has collaborated with notable colleagues, including Ulrich Brennscheidt and Otmar Herrgott, who serves as the Legal Representative. These collaborations have further enhanced her research efforts and contributed to the success of her innovations.

Conclusion

Carol Ward is a trailblazer in the field of lung cancer research, with a focus on developing methods to improve chemotherapy effectiveness. Her patent and ongoing work at Hoffmann-La Roche Inc. highlight her commitment to advancing medical science and improving patient care.